Envista Holdings Corp is set to announce its latest quarterly earnings on Tuesday, May 5th, with a consensus estimate of $0.31 EPS.
Today, NVST's price stands at $26.55, showing a decrease of 22 cents (-0.822%) from the previous close. The trading volume is $1.73 million, representing a 61.44% increase over the average.
NVST has seen a five-day streak of price decline, resulting in a $-1.3 absolute change (-4.67%) from the starting price of $27.85.
In the last quarterly report on Wednesday, February 4th, NVST reported an EPS of 20 cents, slightly below the consensus estimate of 0.32. The company awaits the upcoming earnings announcement.
Envista Holdings Corp generated a free cash flow of $91.7 million, with a net change in cash of $77.8 million. Operating cash flow amounted to $108 million, while capital expenditure stood at $-16.3 million.
With a revenue of $750.6 million, NVST reported a net income of $32.9 million, resulting in an EPS of 20 cents. The company maintained a gross profit margin of 55.04%.
Key ratios for NVST include a net profit margin of 4.38%, return on equity of 1.06, and a price-to-earnings ratio of 27.12.
Envista Holdings Corp holds total assets worth $5.68 billion, with total liabilities amounting to $2.57 billion, resulting in a net debt of $496.4 million.
This comprehensive overview captures the recent performance and financial standing of NVST, setting the stage for the upcoming earnings release.
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.